After a proof-of-concept clinical trial failed to meet its main goal, Immunovant announced that it will not pursue further development of its experimental therapy IMVT-1402 (imeroprubart) as a treatment for cutaneous lupus erythematosus (CLE). Immunovant sponsored a Phase 2 study (NCT06980805) that compared IMVT-1402 with a placebo…
Information about lupus
About
Lupus is an autoimmune inflammatory disease that can affect multiple systems in the body.
Causes
While the cause of lupus is often unknown, it is possibly due to a combination of genetics and the environment.
Symptoms
Lupus affects people in different ways, and symptoms vary among patients. Symptoms come and go during periods called flares.